The Manila Times

Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib ...

TARPON SPRINGS, Fla., March 6, 2026 - Allarity Therapeutics, Inc. ("Allarity” or the "Company”) (NASDAQ: ALLR), a Phase 2 ...

Allarity Therapeutics, Inc.: Allarity Therapeutics Closes $20 Million Financing to ...

Financing Expected to Fund Completion of Phase 2 Ovarian Cancer TrialFinancing Supports Acceleration Toward Pivotal Trial and CommercializationFinancing Structured ...